Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polycystic Ovary Syndrome × Vitamin D × Clear all

Phase

Phase NA 2 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 2 Obesity 2 Vitamin D Deficiency 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Kidney Neoplasms 1 Helicobacter Infections 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Metformin 9 Clomiphene 6 maltodextrin 2 artenimol 2 Sugars 2 Spironolactone 2 Pioglitazone 2 Orlistat 2 Inositol 2 Contraceptives, Oral 2 Cholecalciferol 2 salicylsalicylic acid 1 licogliflozin 1 follitropin alfa 1 elagolix 1 Vitamin E 1 Vitamin D 1 Thioctic Acid 1 Tablets 1 Sodium Salicylate 1 Resveratrol 1 Pentoxifylline 1 Ovulation Induction 1 Linseed Oil 1 Leuprolide 1 Letrozole 1 Inulin 1 Interleukin 1 Receptor Antagonist Protein 1 Gonadotropins 1 Folic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02656121 2018-11-16

PCOSD

Ain Shams University

Phase 2 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡